Layoffs
Filter News
Found 118 articles
-
The first Novartis executive has fallen in the wake of the $1.2 million payment to President Donald Trump’s attorney for consulting work.
-
aTyr Pharma Slashes 30% of Employees as it Initiates Corporate Restructuring Following ORCA Failure
5/14/2018
Shares of San Diego-based aTyr Pharma are down nearly 20 percent this morning after the company announced a corporate restructuring plan that includes a 30 percent reduction of staff following failures of its preclinical ORCA program. -
Amneal Announces Actions to Streamline Operations and Capture Cost Synergies
5/11/2018
Company will close its Hayward, California-based facilities and operations.
-
On April 16, Celldex Therapeutics reported that its Phase IIb trial of glembatumumab vedotin (glemba) failed in a trial of metastatic triple-negative breast cancer. Now the company has filed with the U.S. Securities and Exchange Commission (SEC) that it is cutting about 20 percent of staff.
-
Shares of Edge Therapeutics were in free fall Wednesday afternoon following the company’s decision to discontinue development of a late stage treatment for adults with aneurysmal subarachnoid hemorrhage (aSAH).
-
Achillion is handing out pink slips to 20 percent of its employees and initiating an operational restructuring plan.
-
The news was revealed in a filing with the SEC.
-
ImmunoGen gave a pipeline progress report and 2017 operating results last week.
-
That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past.
-
The first of the pink slips at Sandoz' generic-drug manufacturing facility in Broomfield, Colo. have been handed out.
-
Koss said affected employees will receive severance benefits and career guidance.
-
The cuts were apparently announced in late January with a WARN notice filed with the state.
-
Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn.
-
A tipster told BioSpace that the layoffs were initially announced by Intarcia CEO Kurt Graves on Jan. 31.
-
Vical announced its restructuring late Tuesday.
-
Novelion will slash an unknown number of jobs as it initiates "significant cost reduction plans."
-
Sanofi to Eliminate 400 U.S. Jobs
1/22/2018
Sanofi has announced major restructuring, which will involve layoffs. -
The layoff leaves 58 percent of FDA employees on the job, which Gottlieb said is higher than the previous shutdown in 2013.
-
The cuts are being made as the company grapples with a debt of between $30 and $35B and a restructuring of its R&D in order to combat dramatically declining revenue from its generic pipeline.